FULL YEAR, 1 JANUARY – 31 DECEMBER 2020 The Redsense Group • Total operating income for the financial year amounted to KSEK 18,159 (14,828). • Net sales for the financial year amounted to KSEK 13,902 (13,265). • Operating result (EBIT) amounted to KSEK -8,024 (-4,594). • Total equity amounted to KSEK 73,166 at the end…
Interim Report Q3 - July - September, 2020 Redsense Medical AB (publ)
FINANCIAL SUMMARY Third quarter, 1 July – 30 September 2020 The Redsense Group · Net sales amounted to KSEK 2,107 (4,645), a 55 percent decrease compared with the corresponding period in 2019. · Profit or loss before tax amounted to KSEK -3,723 (-590). The Swedish Parent Company · Net sales amounted to KSEK 1,595 (3,257).…
Interim Report Q2 - April - June, 2020 Redsense Medical AB (publ)
FINANCIAL SUMMARY Second quarter, 1 April – 30 June 2020 The Redsense Medical Group • Net sales amounted to kSEK 5,292 (2,758), a 92 percent increase compared with the corresponding period in 2019. • Profit or loss before tax amounted to kSEK 93 (-1,388). The Swedish Parent Company • Net sales amounted to kSEK 3,946 (2,060).…
Interim Report Q1 - January – March, 2020 Redsense Medical AB (publ)
FINANCIAL SUMMARY First quarter, 1 Januari – 31 Mars 2020 The Group · Net sales amounted to kSEK 4,996 (1,964), a 154 percent increase compared with the corresponding period in 2019. · Earnings before tax amounted to kSEK 241 (-706). · Total equity amounted to kSEK 14,947 at the end of the period. · Available…
FULL YEAR, 1 JANUARY – 31 DECEMBER 2019 The Group • Total operating income for the financial year amounted to kSEK 13,863 (8,702). • Net sales for the financial year amounted to kSEK 13,265 (7,006). • Operating result (EBIT) amounted to kSEK -3,742 (-6,829). • Total equity amounted to kSEK 8,694 at the end of…
Interim Report - January – September, 2019 Redsense Medical AB (publ)
Quarter 3, 2019, showed an increase in sales of 103% versus same period last year and is the strongest in the company’s history. The growth is driven by the US market.
Interim Report - January – June, 2019 Redsense Medical AB (publ)
The strongest result in the company’s history The first half of 2019 is the strongest yet in the company’s history, with an increase of 30% versus same period last year. Q2 was up 12% versus same period last year and is the strongest quarter on record for the company and we can already now estimate…
We're not around right now. But you can send us an email and we'll get back to you, asap.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience. SettingsACCEPT
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.